Arrakis Therapeutics Company
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
Investors
.jpeg)
Technology:
Biopharma, Biotechnology, Medical, Pharmaceutical
Industry:
Early Drug Development
Headquarters:
Waltham, Massachusetts, United States
Founded Date:
2015-01-01
Employees Number:
101-250
Funding Status:
Early Stage Venture
Investors Number:
14
Total Funding:
113000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-04-18
Last Funding Type:
Series B
Register and Claim Ownership